Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
AllenM,
I hear you... However, I'm trying to model their Q1 revenues. Why wouldn't they break out the number (test sales)? I don't think Mr. Market liked it. We are now trading at 1.6X forward sales plus cash. 1.1X forward sales plus cash was the low we briefly hit last quarter.
Do you have a guess as to how many tests were sold? Price per test? Total sales? I saw an estimate of 300K @ $8.00 per test = $2.4M on another board. Is this even close? The price seems awfully low to me...
Thanks:)
Anyone got a clue to how many tests/kits were sold in Q4? Price per kit? Total Sales? Did I miss something...
Test Sales projection for Q1??
Hide the ball? Sandbag for Q1??
I thought the company would sell at least 300K tests @ $24 = $7.2M in the June quarter.
Thanks:}
I also added today:)
Well, we know they sold 100K tests kit(s) April/May @ +/- $25(?) = $2.5M.
Additional 300K tests kit(s) in June = $7.5M.
$22M+ Q4? Price Target?
Cheers
Well, I'm back in the saddle again to see if the good Doctor can pull a rabbit out of his ________. I think it's the 5th time this year. Short term price target is $12+ unless we get the "Big Pharma News" $18+. We'll see if he's got any game soon.
GLTA
Cheers:)
I knew Hayward would fail! He should have been fired last year! What is the board waiting for???
I have been out since the last big spike but should have shorted the stock....
They need a leader who knows how to SELL and make a profit! So much IP and potential!
It's CRAZY!!!
GLTA
Cheers:}
Park,
Sold my APDN 4wk or so swing this morning for a double (4th or 5th time this year).
You have to trade the stock because Hayward doesn't know how to make a profit! 500K in revenue last quarter is pathetic! Remember he was almost throw out of the company last year. The "Used Biotech Salesman"/CEO... LOL
A long time ago, I used to think the Good Doctor knew what he was doing but it's all Magic! He has to prove he can generate real numbers or the stock won't hold. Most investors aren't that stupid.
Buy when the stock is oversold and sell on the Hayward Hype until proven otherwise. Awesome technology and massive intellectual property but leadership is_____________. JMHO
GLTA
Cheers:}
Maybe APDN is waiting on a check and did sign on. Who knows with these guys...
I believe the APDN PCR solution/technology is the most flexible/cost effective and keep in mind their past history with Takis (cancer vaccine). They already sent the vaccines for the fall clinical trials. If everything went south, you'd think we would have herd something by now. JMHO
PR this week?
Cheers
COVID-eVax .
As part of the agreement, Rottapharm Biotech will provide Takis with its expertise in the development of innovative drugs, in addition to financial support until at least the completion of phase I / II of clinical trials. The first 3 million Euros have already been agreed on the ongoing programs.
In the field of vaccines against the new Coronavirus there are several technological platforms. The one being developed by Takis and Rottapharm Biotech is based on DNA: a fragment of DNA is injected into the muscle and promotes the synthesis of a portion of the " Spike " protein of the virus, stimulating a strong immune reaction (both antibody and cellular) by the body which prevents infection.
The efficiency of the process is increased by the "electroporation" technique, which favors the passage of DNA inside the cells in a simple, rapid and without side effects thanks to mild and short electrical stimuli. In terms of "electroporation" Takis has been collaborating for years with IGEA , an Italian company whose electroporator is already available in over 200 hospitals in Europe. The three companies together are collaborating in the creation of a system for a wider and more widespread diffusion.
The results of the vaccine administration in the animalfrom experiment they have shown a strong immune response that neutralizes the virus, blocking its replication in the cells. The development program now includes the completion of laboratory studies and the production of the first quantity of the vaccine, which has already started to arrive at the first clinical study in the autumn .
"We are very happy to collaborate with Rottapharm Biotech" said Luigi Aurisicchio, Takis CEO and Scientific Director . “This synergistic opportunity will give new stimuli to this ambitious project. We hope that this collaboration will be useful to aggregate other public and private collaborations, to accelerate the development of this fruit of Italian research, especially for large-scale production ".
The technology under development has many advantages over others, including the possibility of being repeated to increase and maintain the immune response, and of being easily adaptable in case the virus "changes" its genetic code over time.
"The collaboration is already fully active," said Lucio Rovati, President and Scientific Director of Rottapharm Biotech. "We immediately made available to Takis not only the capital for the first phase of experimentation, but above all the technical support of our scientific managers, creating a team of high skills." Rovati then added "In agreement with the international scientific community, we believe it is of great importance to have different vaccines available and on different technological platforms, in order to better prevent a possible return of the emergency".
Two weeks late is plenty of time, don't you think?
I took a swing this morning... target $12.25. Do you have a target?
Cheers:)
Well, if you get the stock up to $20.00 with a real business plan, he can raise $20 million with only a 1 million share dilution. That's how it's done if you want to create shareholder value.
Wishful thinking??
So far, really disappointed....
I hear ya Park...
I've made good money trading the stock and warrants this year. However, I really thought it would be hard for even Hayward to _______ the EUA up. It's amazing to me that they haven't thrown his ass out!
Cannabis was a disaster (another one)! Anyway, he should be on short leash (new board). You'd think the 500K quarter was the last straw. Let's hope they put a fire under his ass to preform this time.
We need constructive news with $ pronto or I sure as hell won't be waiting around.
Cheers:)
Stops got taken out today... need PR from the wizard.
I want the price to hold and make a new high with all the momentum built up over the past two months. Knock, Knock...
Where is Hayward with revenue projections from EUA??? Anything?? NY State contract/other??? What has he been doing the last four months? He should of had a deal done the week of the announcement! They are in NY for God's sake!
APDN needs a leader who can SELL and CLOSE!
I can't believe anyone defends this guy on this board.... WTF?
We now need to hold at this price level or down we go...
If I had any confidence in this Joker, I'd would buy more on this pull back. I don't!
Always the same BS... frustrating!
JMHO
Does Hayward have any orders/contracts in place?
What has he been doing the past two months while waiting on EUA?
What is your confidence level in any positive revenue/new partnerships announcement before the next raise? Time frame?
Will he _________ this up?
I thought he would give some guidance this week. Disappointed....
Cheers
Hey Foose,
I'm back in the saddle again... watching closely.
I didn't hear Hayward's presentation. Any news to hang your hat on?
GLTA
Thanks
I agree... It's CRAZY! Think about the amount of money dumped into this company for $500K in revenue this past quarter. I've never seen anything like it!
I'll most likely trade it with a tight stop, just in case he pulls a miracle out of his________. They are a New York company. I would imagine the possibility of a small business set-aside contract. Who knows if he's savvy enough to make that happen....??
Our common stock is listed on The Nasdaq Capital Market under the symbol “APDN.” Each prospectus supplement will contain information, where applicable, as to our listing on any securities exchange of the securities covered by the prospectus supplement. The aggregate market value of our outstanding common stock held by non-affiliates was $47,216,546 based on 4,677,995 shares of outstanding common stock, of which 462,232 shares are held by affiliates, and a price of $11.20 per share, which was the last reported sale price of our common stock as quoted on The Nasdaq Capital Market on May 18, 2020. Pursuant to General Instruction I.B.6 of Form S-3, in no event will we sell securities registered in a public primary offering with a value exceeding more than one-third of our public float (the market value of our common stock held by our non-affiliates) in any 12 calendar month period so long as our public float remains below $75.0 million. We have not offered any securities pursuant to General Instruction I.B.6 of Form S-3 during the prior 12 calendar month period that ends on and includes the date of this prospectus. As of May 18, 2020, one-third of our public float is equal to approximately $15.7 million.
It looks like Hayward wants to have a war chest of $20-30M cash in the bank this year. He's going for it! Now, will he be able to generate sales without destroying shareholder value??
Well, still not sure about the cost. The pricing is all over the map for various PCR Test Kits. I guess you have to figure in the type of equipment used, availability, speed, reliability, product material, labor, ease of use, market forces, etc...
It does look like the lower end price points are $20-$30.
Can Hayward sell 1M this year? Will he do a raise first?
Wow! Thanks for your incredible contribution to the subject matter. Brilliant!
Does anyone have a handle on how much the Applied DNA test kits may sell for? Crazy Numbers....
I went back and listened to the conference call and realized these PCR Based Test Kits can be fairly expensive. The basic 5 min Test Kit sell for $28.00. Are we talking $125.00???
1,000,000 PCR Test Kits @ $125 = $125,000,000 X 65% Margin = $81,250,000
$81,250,000 - $12,000,000 (Hayward's Yearly Loses) = $69,250,000
$69,250,000/5,000,000 Shares Outstanding = $13.85 Share
$13.85 X 20 Multiple = $277 per share
100,000 Kits X $125 = $12,500,000
Is this for real?? Do you think I'm off the reservation?
I found this example:
https://igenex.com/igenex-covid-19-testing/
Others? What do you guys think?
Thanks
My guess of $28.00 per kit was based on an average cost for similar types of kits. Not real sure...
Hey Rode, I'm waiting... same set-up as last week. Fill the gap and hope for the best.
How much confidence do you have in Hayward to get a deal done this week or next?
Do you have an idea on how much they may charge per kit?
Good Day Mr. Shark,
Thanks for all the interesting information! Of course, I don't trust Hayward as far as I can throw him... $500K in revenue last quarter, pathetic!
All that being said, I think we have a few more short term plays left in the tank. So far, it's been working! Will the good Dr. deliver the contracts?
@ $9.75 we fill the gap.
GLTU
Cheers:)
Call me crazy!
Dr. Magic sells/produces 1,000,000 Test Kits @ $28.00 (avg. standard rate) with a conservative margin of 65% this year.
$28,000,000 X 65% = $18,200,000 profit Test Kits
-2,500,0000 X 4 qtrs. = -$10,000,000 Hayward's core losing business
$8,200,000 Earnings/5,000,000 Shares (if he doesn't raise) = $1.64 EPS
$1.64 EPS X 20 (Biotech Multiple) = $32.80 Share EOY 2020
Doable in 2020? There's a lot of relief funds and need in NY and NJ alone. Can he screw this up?
What do you guys think?
Rode, How did you do? Are you looking to get back in anytime soon?
Cheers:)
Hey Foose,
I'm back on the sidelines after another successful trip. Any thoughts on a new entry point and a guess on next PR date from the magic man?
$9.75 may be the ticket...
Cheers
Back in the Saddle again... The price action looks like a winner!
Thanks for the update:)
Does anyone have a guess as to when the Test Kits may get approved by the FDA? Is the 15th unrealistic?
I agree... this company has over 250M duped into the tech and patents over the years. Also, remember Danaher (owns Videojet) is sitting out there which is still the perfect fit. JMHO
If the FDA/Colorcon combo is for real.... watch out! It will be interesting to see if we get the 750K (2nd half) from Colorcon. Next call?
I've traded the Warrants and the stock this year. So far, so good:)
I thought we would touch the 200 day and sit around there for the next leg up. Still may... 3 days down after the last spike. We sure are moving in the right direction. I'm starting to think that Hayward may actually know what he's doing. I Know... Madness! LOL
Hey Rode, I wasn't fast enough! LOL It's crazy where we are now... who would of guessed this:}
Any guess on when the good Doctor gets approval? I was thinking by the 15th...
Do you think we get to the 200 MA? Thinking about taking another position
around there... thoughts
Cheers
Hey Foose,
Any thoughts on where you're looking to get back in (trading position)? I've been doing well with our buddy Hayward this year. Sold my Warrants this morning:)
Thanks
Shark,
Hayward Q4 call: "We further evolved our tagging methods and initial marketing with our partner Colorcon for proof pharmaceuticals, presented at industry conferences, and we increased our dialogue with FDA. We completed commercial shipments to a dietary supplements company, which represents our first steps into this large market."
What does "we increased our dialogue" mean??
Which dietary supplement company?? Target revenue from shipments?? How about a 2020 royalty/revenue goal from Colorcon sales [Hayward missing in action]??
Thanks for the follow up!:]
GL
GO CAPS!
I would think Q1 revenue of $750K is material. IR question? Also, an honest explaination of the ACG deal would be beneficial.
Applied DNA inks deal with Colorcon which grants use of molecular tags in the pharmaceutical and nutraceutical markets
Apr. 5, 2018 7:59 AM ET|About: Applied DNA Sciences, Inc. (APDN)|By: Mamta Mayani, SA News Editor
Applied DNA Sciences (NASDAQ:APDN) signs a License and Cooperation Agreement and a related Supply Agreement, effective March 31, with Colorcon, Inc.
Under the terms of the Agreements, Applied DNA grants Colorcon exclusive worldwide right to use the Company’s molecular tags and associated authentication technologies in film coatings for solid oral dosage form (“SOD”) applications, and non-exclusive rights to use the Company’s technologies in inks and colorants for SOD applications.
Pursuant to the Agreements, Applied DNA will supply taggant and authentication materials in exchange for long-term royalties on the sale of Colorcon products. Further, the first of two milestone payments is payable to Applied DNA with the signing of the Agreements. Second milestone payment will be received upon initial approval by a regulatory authority.
The Agreements will expire on the later of October 1, 2032 or the last expiration date of any patent licensed pursuant to the Agreements.
Shares are up 13% premarket.